Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01703793 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy Study in Subjects With Seborrheic Dermatitis
A Phase 2 study, sponsored by Medicis Global Service Corporation.
- Completed
- Registry status
- Phase 2
- Development phase
- 240
- Enrollment target
NCT01703793 is a Phase 2 study that has completed, run by Medicis Global Service Corporation. The registered enrollment target is 240 participants.
The verdict
NCT01703793, a Phase 2 study, has completed, sponsored by Medicis Global Service Corporation.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 240 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if two test products are safe and effective in the treatment of seborrheic dermatitis.
Interventions
- DRUG Vehicle (placebo)
- DRUG Test Product 49778
- DRUG Test Product 10156
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2012-09 |
| Est. Completion | 2013-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01703793
The ClinicalTrials.gov registry entry for NCT01703793 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medicis Global Service Corporation, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Vehicle (placebo) is the first listed.
NCT01703793 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01703793 about?
NCT01703793 is a clinical study titled "Safety and Efficacy Study in Subjects With Seborrheic Dermatitis". The purpose of this study is to determine if two test products are safe and effective in the treatment of seborrheic dermatitis.
What is the current status of trial NCT01703793?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 240 participants. The study started on 2012-09. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01703793?
The interventions under investigation include: Vehicle (placebo) (DRUG), Test Product 49778 (DRUG), Test Product 10156 (DRUG).
Who is sponsoring clinical trial NCT01703793?
This trial is sponsored by Medicis Global Service Corporation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.